Acetaminophen is generally a safe and effective pain reliever, but it can can lead to serious side effects and liver damage ...

Novartis receives third FDA approval for oral Fabhalta® (iptacopan) – the first and only treatment approved in C3 glomerulopathy (C3G) Fabhalta is the only oral alternative complement pathway ...